Tuzi, A., Lombardi, D., Crivellari, D., Militello, L., Perin, T., La Grassa, M., … Veronesi, A. (2013). Epirubicin and Docetaxel as neoadjuvant treatment of hormone receptor positive, HER-2 negative breast cancer: results from two successive phase II studies. Radiology and Oncology, 47(1). Retrieved from https://radioloncol.com/index.php/ro/article/view/728